BioSpace News Archive

Human Recombinant Insulin Market: Rising Number of Patients Suffering from Diabetes to Drive the Market

Advent of insulin is key event in the history of diabetes treatment.

September 8, 2022
·
5 min read
Liver Disease Treatment Market: Increasing Prevalence of Liver Diseases due to the Side Effects of Drugs to Drive the Market

The liver disease treatment market is anticipated to chart an impressive growth trajectory over the forecast period from 2020 to 2030.

September 8, 2022
·
5 min read
Thrombosis Drugs Market Size, Analytical Overview, Growth Factors, Demand, Trends and Forecast to 2026

The report suggests that the rise in geriatric population, which is more susceptible to thrombosis events, globally, is likely to boost the demand for thrombosis drugs during the forecast period.

September 8, 2022
·
6 min read
C-Reactive Protein Testing Market – Know Latest Trends & Forecast for Long-Term Business Planning Up to 2030

The C-reactive protein testing market is predicted to display sluggish growth over the forecast period of 2020 to 2030.

September 8, 2022
·
6 min read
Drug Development

Press Release: Dupixent® (dupilumab) late-breaking Phase 3 data at EADV 2022 showed significant improvements in signs and symptoms of prurigo nodularis

Detailed positive results from the Phase 3 PRIME trial evaluating Dupixent® (dupilumab) in adults with uncontrolled prurigo nodularis were presented today in a late-breaking session at the European Academy of Dermatology and Venereology (EADV) 2022 Congress.

September 8, 2022
·
16 min read
The GelMA Company wins $510,000 Contract with the Government of Canada

The GelMA Company, a biotechnology start-up that produces high-quality biomaterials using a patented process, is excited to announce that it has secured a $510,000 contract with its new customer and strategic partner, the Government of Canada.

September 8, 2022
·
3 min read
MaaT Pharma Announces Participation in Three Upcoming Investor Conferences in September 2022

MaaT Pharma announced that Hervé Affagard, CEO and co-founder of MaaT Pharma, and Siân Crouzet, CFO of MaaT Pharma, will participate in three upcoming investor conferences.

September 8, 2022
·
2 min read
InMed Pharmaceuticals Provides Update on its Core Research and Development Programs and BayMedica Business

InMed Pharmaceuticals Inc., a leader in the research, development and manufacturing of rare cannabinoids and cannabinoid analogs, announces an update on its research/development and commercial activities.

September 8, 2022
·
6 min read
Genetown

Waters Corporation Presentation at the Bank of America 2022 Global Health Care Conference

Waters Corporation Udit Batra Ph.D., President and Chief Executive Officer, will participate at the Bank of America 2022 Global Healthcare Conference in London, with a fireside chat on Wednesday, September 14th, 2022 at 9:05AM BST / 4:05AM ET.

September 8, 2022
·
1 min read
Biotech Beach

Predicine to Present New Data at ESMO 2022 Demonstrating the Utility of its Portfolio of Liquid Biopsy Tests for Cancer Patients

Predicine, Inc., a global molecular insights company, announced today that it will present four posters at the ESMO conference being held September 9-13, 2022, in Paris, France.

September 8, 2022
·
2 min read